A meta-analysis assessing the therapeutic efficacy and safety of anlotinib in combination with chemotherapy for small cell lung cancer

This meta-analysis aimed to assess the effectiveness and safety of combining anlotinib with chemotherapy in treating patients with small cell lung cancer (SCLC).